TABLE 5.
Outcomes in patients with CRE infections.
| CPE (n = 69) | Non-CPE (n = 59) | Total (n = 128) | p value | |
|---|---|---|---|---|
| DOOR at 30 days | 0.180 | |||
| Alive without events | 17(24.6%) | 20(33.9%) | 37(28.9%) | |
| Alive with one event | 16(23.2%) | 15(25.4%) | 31(24.2%) | |
| Alive with two events | 11(15.9%) | 8(13.6%) | 19(14.8%) | |
| Alive with three events | 4(5.8%) | 2(3.4%) | 6(4.7%) | |
| Death | 21(30.4%) | 14(23.7%) | 35(27.3%) | |
| DOOR components at 30 days | ||||
| Not discharged | 31(44.9%) | 24(40.7%) | 55(43.0%) | 0.628 |
| Lack of clinical response | 43(62.3%) | 33(55.9%) | 76(59.4%) | 0.463 |
| Renal failure | 13(18.8%) | 9(15.3%) | 22(17.2%) | 0.592 |
| Total LOS, days | 30(16–52) | 26(15–50) | 27(15–50.75) | 0.261 |
| LOS after isolation a , days | 20(11–32.5) | 16(8–26) | 14.5(7–26) | 0.220 |
| 30-day mortality | 21(30.4%) | 14(23.7%) | 35(27.3%) | 0.396 |
| 90-day mortality | 26(37.7%) | 16(27.1%) | 42(32.8%) | 0.205 |
| 90-day readmissions | 16(23.2%) | 9(15.3%) | 25(19.5%) | 0.259 |
| Clinical response | 26(37.7%) | 25(42.4%) | 51(39.8%) | 0.589 |
| Disposition | 0.444 | |||
| Death | 26(37.7%) | 16(27.1%) | 42(32.8%) | |
| Home | 42(60.9%) | 42(71.2%) | 84(65.6%) | |
| Long-term care | 1(1.4%) | 1(1.7%) | 2(1.6%) |
Data are expressed as n (%) of patients for categorical variables and median (IQR) for continuous variables as appropriate.
DOOR, desirability of outcome ranking; LOS, length of hospital stay.
a
Excluding cases who died in hospital.